U.S. markets open in 5 hours 37 minutes
  • S&P Futures

    3,418.25
    -33.50 (-0.97%)
     
  • Dow Futures

    27,883.00
    -306.00 (-1.09%)
     
  • Nasdaq Futures

    11,570.75
    -92.75 (-0.80%)
     
  • Russell 2000 Futures

    1,613.80
    -21.80 (-1.33%)
     
  • Crude Oil

    38.69
    -1.16 (-2.91%)
     
  • Gold

    1,901.70
    -3.50 (-0.18%)
     
  • Silver

    24.33
    -0.34 (-1.40%)
     
  • EUR/USD

    1.1850
    -0.0018 (-0.15%)
     
  • 10-Yr Bond

    0.8410
    0.0000 (0.00%)
     
  • Vix

    29.90
    +1.79 (+6.37%)
     
  • GBP/USD

    1.3018
    -0.0020 (-0.15%)
     
  • USD/JPY

    104.8170
    +0.1270 (+0.12%)
     
  • BTC-USD

    13,061.41
    -15.60 (-0.12%)
     
  • CMC Crypto 200

    262.42
    +0.96 (+0.37%)
     
  • FTSE 100

    5,860.28
    +74.63 (+1.29%)
     
  • Nikkei 225

    23,494.34
    -22.25 (-0.09%)
     

Inogen to Announce Second Quarter 2020 Financial Results on Tuesday, August 4th, 2020

·1 min read

Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will release second quarter 2020 financial results after market close on Tuesday, August 4th, 2020. The Company will host a corresponding conference call beginning at 1:30pm PT/4:30pm ET.

Individuals interested in listening to the conference call may do so by dialing (877) 841-3961 for domestic callers or (201) 689-8589 for international callers. Please reference Inogen to join the call. To listen to a live webcast, please visit the Investor Relations section of Inogen's website at: http://investor.inogen.com/.

A replay of the call will be available beginning, August 4th, 2020 at 3:30pm PT/6:30pm ET through 3:30pm PT/6:30pm ET on August 18th, 2020. To access the replay, dial (877) 660-6853 or (201) 612-7415 and reference Access Code: 13672721. The webcast will also be available on Inogen's website for one year following the completion of the call.

Inogen has used, and intends to continue to use, its Investor Relations website, http://investor.inogen.com/, as a means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD. For more information, visit http://investor.inogen.com/.

About Inogen

Inogen is innovation in oxygen therapy. We are a medical technology company that develops, manufactures and markets innovative oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.

For more information, please visit www.inogen.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200707005082/en/

Contacts

Investor Relations Contact:
Matthew Pigeon
mpigeon@inogen.net

Media Contact:
Byron Myers
bmyers@inogen.net